FDA: Foreign Manufacturers to Help Alleviate US Infant Drug Shortages Next Week
Continued manufacturing issues at both American Regent and Hospira have caused the US FDA to begin allowing foreign imports as early as next week to combat a shortage of critical drugs for infants, the agency told us.